Related Experiment Videos
An integrated proteomic approach to studying glomerular nephrotoxicity.
P Cutler1, D J Bell, H C Birrell
1Department of Analytical Sciences, Smith Kline Beecham Pharmaceuticals, Harlow, UK. paul_cutler-1@sbphrd.com
Electrophoresis
|December 28, 1999
Summary
Puromycin aminonucleoside (PAN) causes nephrotic syndrome in rats, similar to human minimal change nephropathy. Proteomics and spectroscopy revealed toxin-induced changes in urinary proteins and metabolites during recovery.
Area of Science:
- Nephrology
- Biochemistry
- Toxicology
Background:
- Puromycin aminonucleoside (PAN) induces nephrotic syndrome in rats, mirroring human minimal change nephropathy.
- Increased urinary protein excretion is a hallmark of PAN-induced nephrotoxicity, occurring 3-6 days post-administration.
Purpose of the Study:
- To investigate urinary protein and metabolite changes during PAN-induced nephrotoxicity and recovery in rats.
- To explore the utility of advanced analytical techniques for mechanistic insights into nephrotoxicity.
Main Methods:
- Two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) for urinary protein profiling.
- High-performance liquid chromatography (HPLC) and proton nuclear magnetic resonance (NMR) spectroscopy for metabolite analysis.
Main Results:
- 2-D PAGE identified distinct urinary protein profiles during PAN-induced nephrotoxicity.
- HPLC and NMR detected toxin-induced alterations in metabolite concentrations, providing a comprehensive molecular picture.
Conclusions:
- Proteomic and metabolomic analyses offer deeper mechanistic understanding of PAN-induced nephrotoxicity compared to traditional methods.
- These integrated techniques can elucidate the complex molecular events underlying kidney injury and repair.